Objectives To ascertain if there has been a change in the pattern of thyroid cancer in Sri Lanka. If so, whether there is a correlation to the implementation of the programme of iodination.
Introduction
An audit of thyroid illness on patients attending the first author's surgical clinic has shown an increasing prevalence of thyroiditis and thyrotoxicosis since the mid 1990s. Such changes occur after iodination programmes [1, 2] . Could the nature of thyroid cancer too be undergoing change, and if so, what changes in the current therapeutic protocols must be effected? We sought answers.
Patients and method
Three hundred consecutive patients with cancer primarily involving the thyroid gland managed by the first author in General Hospital Kandy (1974-81), General Hospital Peradeniya (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) hospitals in Kandy (1979 Kandy ( -2001 ) over a 28-year period were reviewed. Patient data for the early period (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) were collected and collated retrospectively from well maintained records, and supplemented by data from patient notes and clinic files. In 1986 an ongoing protocol based prospective audit was established. The data was digitised and audited on an Excel spreadsheet. The 300 patients were divided for purposes of this study into three equal cohorts with 100 consecutive patients in each. They were seen over the periods 1974-1986, 1987-1995 and 1995-2001. Papillary follicular carcinoma was classified with papillary carcinoma. In the retrospective group (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) ) detailed data of the extent of spread was not always available. Staging of thyroid cancers and separation into high-risk and low-risk prognostic groups in differentiated thyroid carcinoma were based on the TNM classification [3] . Thyroid cancer in multinodular goitres, i.e. goitre present for > 10 years were studied with approximately equivalent number of patients, over three time periods 1981-1991 (n=25), 1992-1996 (n=23), 1997-2001 (n=23) .
The data were analysed using appropriate statistical tests. Table 1 shows the prevalence of the dominant histological patterns in the three groups of patients over the specified times. A highly significant reduction of anaplastic tumours versus differentiated tumours in recent years was observed.
Results
The others (n=15) referred to in the table include lymphomas (n=5), papillary carcinomas with squamous differentiation (n=3), a squamous carcinoma and a mucoid carcinoma of the thyroid. In five thyroid malignancies, specific histological type of malignancy was not available. Table 2 shows the extent of spread at presentation of differentiated (i.e. papillary and follicular) thyroid cancer seen in the respective periods. An increase in diagnosis of differentiated tumours without extrathyroidal spread after the mid 1990s is a highly significant feature (p < 0.001). In view of the wide prognostic differences associated with the age of onset of differentiated Extent 1974 Extent -1978 Extent 1979 Extent -1983 Extent 1984 Extent -1988 Extent 1989 Extent -1993 Extent 1994 Extent -1998 Extent 1999 thyroid carcinoma, a review of the age and the stage at presentation based on the TNM classification is given in Table 3 . Further, the relative prevalence of high and low 
Cancer in multinodular goitre
In 71 of the 300 patients with thyroid cancer at presentation, a pre-existing goitre of at least 10 years duration was described (Table 5 ). In 66% of the 71, the goitre had been present for 15 or more years. Table 6 shows the histological patterns of tumour in the cohorts selected. A highly significant (p<0.001) increase in the prevalence of papillary cancer from 6.3% in the pre-1996 period to a 39% in the post-1996 period is observed. A significant reduction in the prevalence of anaplastic tumours from 25% to 0 is also a feature in such malignant transformations during these periods. Only three patients in the group of 71 had a tumour equal to or smaller than 1.5 cm. Table 7 indicates the extent of the tumour at presentation in patients with multinodular goitre. A significant X 2 6.8 df 2 (p=0.033) reduction in the prevalence of extra-thyroidal spread has been observed more recently in patients with malignant transformation of their goitres. 
Discussion
Geographical variation in the nature of thyroid carcinoma is well documented [4] . Anaplastic tumours are of high prevalence in iodine deficient areas [5] . It is hypothesised that this may be due to chronic stimulation of the thyroid by TSH [6] . Yet others claim that the unquestioning acceptance of the presence of a goitre in the neck of people in endemic areas delays diagnosis and permits the somewhat indolent differentiated tumours to transform to undifferentiated tumours [6, 7] .
Several studies have shown that iodination programmes cause prevalence of aggressive tumours to dwindle and present earlier [8] , a dramatic and salutary response. The data presented in our study appear to reflect a similar response.
The iodination programme in Sri Lanka was formally initiated in 1995. Though several attempts were made previously, they were unsuccessful due to social unrest in the country. Two thirds of salt produced in Sri Lanka are iodised by inappropriate measures adopted by small scale private producers [9] . However, the median iodine content of salt sampled from all provinces (except the North) did not show a wide variation [9] , with a natural mean of 30.7 ppm, which was considered satisfactory [9] . Table 1 shows a highly significant decline in aggressive tumours beginning in the late 1980s and accelerating in the late 1990s. Further, when one reviews differentiated thyroid carcinoma (Table 2 ) an increasing prevalence of early tumours is seen after 1994 which could be consequent to iodination.
When we reviewed age-based data on differentiated thyroid cancer using the widely accepted TNM classification (Table 3 ) a lower prevalence of high-risk groups is noted post-1994, which did not reach statistical significance. Though the prevalence of "incidental" carcinoma when compared to clinical carcinoma (Table 6) had not changed, the nature of cancerous transformation in multinodular goitre has changed to less aggressive tumours with a reduced extent of spread at presentation (Table 7) .
Anaplastic carcinoma of the thyroid is considered one of the most rapidly progressing soft tissue malignancies. It is dominantly seen in the over 60-year age group. Despite the demographic increase in this age group, the reduction in prevalence is significant and suggests dramatic decline in both morbidity and mortality for carcinoma of the thyroid in Sri Lanka.
Medullary carcinomas remain unaffected by iodination, being derived from parafollicular cells that take no part in iodine metabolism. The numbers of medullary carcinoma in this study are too small to make any valid conclusions.
Rats and mice starved of iodine or fed on goitrogenic food developed thyroid cancer [10, 11] . Experimentally, iodine deficiency increases the growth response of normal thyroid tissue to thyroid stimulating hormone (TSH) [12] .
However, no consistent elevation of TSH has been observed in humans with thyroid carcinoma [13] . Many endemic goitre regions have populations with chronically increased TSH levels. One such endemic region well studied is Cali, in Colombia, where a high prevalence of cancer has been established [4, 5] . The tumours seen in such endemic regions are more aggressive, i.e. anaplastic or follicular [4] . In contrast, in countries such as Iceland where high dietary iodine is known to be associated with a low TSH level in the population, a high prevalence of papillary carcinoma is noted [15] .
Some authors working in iodine rich areas such as Iceland suggest that TSH could play different roles encouraging papillary carcinoma in iodine rich areas and follicular carcinoma in areas with iodine deficiency. The papillary follicular ratio in our study was 1.4:1; 0.8:1 and 1.8 :1 in 1974-1987 in 1987-1995 and 1995-2001 respectively. The figures are similar to those from iodine deficient Cali in Colombia [3] , 1.3:1. In Salta, the Argentina ratio increased from 1.7:1 to 3.1:1.2. The slight improvement in the last 10 years may be heralding this change that seems to be present in countries such as Scotland (3.5:1) and Iceland (6.5:1) where iodine availability is sufficient or even in excess [15] .
In conclusion, there seems to be sufficient clinical data to suggest that the morbidity and mortality from thyroid carcinoma could be decreasing and that iodination of salt may be responsible for this change.
